Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

Clinical trial NCT00731679 · COMPLETED

Trial details

NCT number: NCT00731679
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Constipation Irritable Bowel Syndrome

Start date: 2008-07-01
Primary completion: 2009-08-01
Enrollment: 623

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.